Myeloma Trial Results Spark Talk of 'Potential Cure' — One-third of patients alive and progression-free 5 or more years after a single infusion ...

The article that dinged AstraZeneca was a Bloomberg piece asserting that the company is in discussions with Summit Therapeutics (SMMT -5.18%) on a formal partnership. Image source: Getty Images.

Less than two months after Vor Bio telegraphed a strategic review, the former cell therapy biotech has made a surprise comeback with a potential $4 billion deal licensing a China-made autoimmune ...

This study aims to understand how food and a P-gp inhibitor affect the absorption and processing of these drugs, which could inform future dosing recommendations and enhance therapeutic efficacy.

This study could significantly impact AstraZeneca’s market position by potentially validating a more effective treatment regimen for T2DM, which may enhance investor confidence.

AstraZeneca paid Japan’s Daiichi Sankyo a whopping $1 billion upfront back in 2020, and tacked on a potential $5 billion in milestone payments, for the chance to co-develop the antibody-drug conjugate ...

Photo: rachel wisniewski/Reuters AstraZeneca and Daiichi Sankyo’s Datroway drug has been approved in the U.S. to treat adult patients with non-small cell lung cancer.

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.

Prospective data for nab-paclitaxel in ovarian cancer are limited, so its use in this study might spark discussions. The choice of nab-paclitaxel in this study is based on the mode of action of ...

Climate Solutions Plastic bag fees and bans help protect beaches and riverbanks, study finds But even places with bag policies are seeing a greater prevalence of plastic bags on beaches and ...

The study combined Enhertu with a medicine called pertuzumab as a first option for patients with HER-2-positive metastatic breast cancer. AstraZeneca and Daiichi Sankyo are seeking approval for ...

In their study published in the journal Nature Machine Intelligence, Sheffield computer scientists in collaboration with AstraZeneca and the University of Southampton have developed a new machine ...